Visipat 0.1% Eye Drop belongs to a group of medicines called antihistamines. It is used to treat seasonal allergic conjunctivitis (infection, itching, redness, and swelling of the eye) caused due to pollens, dust, animal fur, and other allergens.

Visipat 0.1% Eye Drop is used in the treatment of allergic disorders.

Uses of Visipat Eye Drop

Treatment of Allergic conditions

Benefits of Visipat Eye Drop

In Treatment of Allergic conditions

Visipat 0.1% Eye Drop provides relief from symptoms such as blocked or runny nose, sneezing, and itchy or watery eyes. This will make it easier for you to go about your daily activities. It can also give relief from allergic reactions after insect bites and symptoms of hives and eczema such as rash, swelling, itching, and irritation. This will improve the appearance of your skin and you may find that your mood and self-confidence improve as well. It rarely has any serious side effects and you may only need to take it on days you have symptoms. Moreover, Visipat 0.1% Eye Drop may make you feel less sleepy as compared to other antihistamine medicines. If you are taking it to prevent getting symptoms you should use it regularly to get the most benefit.

Side effects of Visipat Eye Drop

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Visipat

Eye pain
Eye irritation
Abnormal eye sensation
Eye discomfort
Sleepiness
Weakness
Dryness in mouth

How to use Visipat Eye Drop

This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off the extra liquid.

How Visipat Eye Drop works

Visipat 0.1% Eye Drop is an antiallergic medication. It works by blocking the action of a chemical messenger (histamine) which is responsible for red, itchy, and watery eyes.

Safety advice

Alcohol

No interaction found/established

Pregnancy

CONSULT YOUR DOCTOR

Visipat 0.1% Eye Drop may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

SAFE IF PRESCRIBED

Visipat 0.1% Eye Drop is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Driving

UNSAFE

Visipat 0.1% Eye Drop may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.

Kidney

No interaction found/established

Liver

No interaction found/established

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Visipat 0.1% Eye Drop

₹76.0/Eye Drop

Olotop Eye Drop

Sunways India Pvt Ltd

₹97/eye drop

28% costlier

Rapidon Eye Drop

Micro Labs Ltd

₹102/eye drop

34% costlier

OLO 1 Eye Drop

Nri Vision Care India Limited

₹90/eye drop

18% costlier

Odin Eye Drop

Optho Pharma Pvt Ltd

₹123/eye drop

62% costlier

Olotak Eye Drop

Pharmtak Ophtalmics India Pvt Ltd

₹82/eye drop

8% costlier

View all substitutes

Quick tips

You have been prescribed Visipat 0.1% Eye Drop to relieve red, itchy and watery eyes caused due to allergic eye diseases.
If you wear soft contact lenses, remove them before putting in these eye drops and wait at least 15 minutes before putting your lenses back in.
Do not touch the tip of the dropper to any surface, or to your eye, to avoid contaminating the eye drops.
Side effects such as eye pain or irritation, dry eyes, abnormal sensation in the eyes, headache may occur after using Visipat 0.1% Eye Drop. These are usually mild and may not be with everyone.
It may cause short term blurring of vision when first used. Use caution before driving or using machines.
Any of the side effects other than mentioned above if occur, do consult the treating physician.
Make sure to use within 4 weeks of opening the bottle.

Fact Box

Chemical Class

Dibenzoxepine Derivative

Habit Forming

Therapeutic Class

OPHTHAL

Action Class

H1 Antihistaminics (second Generation)

Patient concerns

Allergic skin conditions in leg

Dr. Atula Gupta

Dermatology

kindly send the Pictures of affected area.

Ive got tested for hiv after 4 months of possible exposure (not sure if partner was +ve and sex was with condom) and results were negative and its been 6 months till date after the possible exposure now i was suffering from blocked nose wnd difficulty in breathing so i went to a chest specialist and was given total ige" test and the report came +ve with very highly elevated ige levels about 2000 ku/l is there anything to worry and is there any relation between total ige levels and hiv im very stressed once again please help."

Dr. Sunil Sekhri

Diabetology

IgE levels indicate that the conditions is allergic

I am suffering with highly allergic conditions of sinus, my nose is always gets block for all seasons. Is there any permanent solution to get rid from allergic sinusitis??

Dr. Gladson Guddappa Uchil

ENT

Please use this app to find and meet a good Allergist in your city to examine you & do the needful. If you are able to make it to Bangalore, I would be very happy to help you out myself. My clinic Healthcare@Basaveshwaranagar is easily navigable on Google Maps.

Related lab tests

Absolute Eosinophil Count

Peripheral Smear Examination

Total IgE

Top Ophthalmologists

Dr. Anita Sethi

MBBS, MD, DNB, Fellowship

4.8 ★

Dr. Prem Vardhan

MBBS, MS, Fellowship, Fellowship

4.5 ★

Dr. Ajay Sharma

MBBS, MS

4.4 ★

Dr. Parul Sharma

MBBS, MS, DNB, Fellowship

4.2 ★

Dr. Vandana Saroha

MBBS, MS, Fellowship

4.5 ★

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Drugs.com. Olopatadine. [Accessed 01 Apr. 2019] (online) Available from:
Olopatadine. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2002 [revised 5 Oct. 2018] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 01 Apr. 2019] (online) Available from:

Marketer details

Name: Asta Visioncare Pvt Ltd

Address: 201, Aims Prospero, Off Atladara Padra Road, Atladara, Vadodara (Gujarat, India)-390012

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.